Clinical Trial Update: Repeated Neurocognitive Measurements in Depressed Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating repeated neurocognitive measurements in patients with major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Jay Fournier | Conditions: Depression, Unipolar | Phase 1, Phase 2 | Status: WITHDRAWN